Apixaban or Warfarin in Patients with an On-X Mechanical Aortic Valve-Reference-Cited by-同舟云学术

Apixaban or Warfarin in Patients with an On-X Mechanical Aortic Valve

Published:2023-06-27 Issue:7 Volume:2 Page:
ISSN:2766-5526
Container-title:NEJM Evidence
language:en
Short-container-title:NEJM Evidence

Author:

Wang Tracy Y.¹,Svensson Lars G.²,Wen Jun¹,Vekstein Andrew¹,Gerdisch Marc³,Rao Vijay U.³,Moront Michael⁴,Johnston Doug²,Lopes Renato D.¹,Chavez Alma¹,Ruel Marc⁵,Blackstone Eugene H.²,Becker Richard C.⁶,Thourani Vinod⁷,Puskas John⁸,Al-Khalidi Hussein R.¹,Cable David G.⁹,Elefteriades John A.¹⁰,Pochettino Alberto¹¹,Wolfe J. Alan¹²,Graeve Allen¹³,Sultan Ibrahim¹⁴,Sabe Ashraf A.¹⁵,Michelena Hector I.¹¹,Alexander John H.¹

Affiliation:

1. Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC

2. Cleveland Clinic, Cleveland

3. Franciscian Health, Indianapolis

4. ProMedica Toledo Hospital, Toledo, OH

5. University of Ottawa Heart Institute, Ottawa, ON

6. University of Cincinnati College of Medicine, Cincinnati

7. Piedmont Heart Institute, Atlanta

8. Mount Sinai Morningside Hospital, New York

9. OSF HealthCare Cardiovascular Institute, Rockford, IL

10. Yale University School of Medicine, New Haven, CT

11. Mayo Clinic, Rochester, MN

12. Northeast Georgia Medical Center, Gainesville, GA

13. MultiCare Institute for Research and Innovation, Tacoma, WA

14. University of Pittsburgh Medical Center, Pittsburgh

15. Brigham and Women’s Hospital, Harvard Medical School, Boston

Publisher

Massachusetts Medical Society

Reference34 articles.

1. Late incidence and determinants of stroke after aortic and mitral valve replacement

2. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines;Circulation,2021

3. Incidence, clinical impact and risk of bleeding during oral anticoagulation therapy

4. Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trial

5. Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-vitamin K versus vitamin K antagonist oral anticoagulants in surgical mitral valve repair or bioprosthetic valve replacement in the first three months after surgery;Revista Portuguesa de Cardiologia;2024-09

2. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS);European Heart Journal;2024-08-30

3. Ten rules for oral anticoagulants prescription after a stroke;Neurology, Neuropsychiatry, Psychosomatics;2024-08-22

4. Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants Compared with Vitamin K Antagonists in Patients with Atrial Fibrillation and Type 2 Valvular Heart Disease: A Systematic Review and Meta-Analysis;Cardiovascular Drugs and Therapy;2024-08-17

5. Acute lower‐extremity arterial thrombosis with immune thrombocytopenia;Clinical Case Reports;2024-08